Risk factors for tuberculosis in inflammatory bowel disease: Anti-tumor necrosis factor and hospitalization

dc.creatorMenéndez S.R.
dc.creatorde Francisco R.
dc.creatorArias-Guillén M.
dc.creatorSaro C.
dc.creatorGarcía-Alvarado M.
dc.creatorDuque J.M.
dc.creatorPalacios J.J.
dc.creatorMuñoz F.
dc.creatorBlanco L.
dc.creatorCastaño O.
dc.creatorPérez-Martínez I.
dc.creatorMartínez-Camblor P.
dc.creatorPérez-Hernández D.
dc.creatorSuárez A.
dc.date.accessioned2020-09-02T22:22:56Z
dc.date.accessioned2022-11-08T20:18:27Z
dc.date.available2020-09-02T22:22:56Z
dc.date.available2022-11-08T20:18:27Z
dc.date.created2020-09-02T22:22:56Z
dc.date.issued2016
dc.identifier108, 9, 541-549
dc.identifier11300108
dc.identifierhttps://hdl.handle.net/20.500.12728/5310
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5142716
dc.languageen
dc.publisherARAN Ediciones S.A.
dc.subjectAnti-TNF
dc.subjectHospitalization
dc.subjectInflammatory bowel disease
dc.subjectRisk factors
dc.subjectTuberculosis
dc.subjectadalimumab
dc.subjectcorticosteroid
dc.subjectinfliximab
dc.subjecttumor necrosis factor inhibitor
dc.subjectadalimumab
dc.subjectinfliximab
dc.subjectmonoclonal antibody
dc.subjecttumor necrosis factor
dc.subjectadult
dc.subjectalbumin blood level
dc.subjectArticle
dc.subjectclinical article
dc.subjectcontrolled study
dc.subjectcoughing
dc.subjectdyspnea
dc.subjectfemale
dc.subjectfever
dc.subjecthospitalization
dc.subjecthuman
dc.subjectimmunosuppressive treatment
dc.subjectinflammatory bowel disease
dc.subjectlength of stay
dc.subjectmalaise
dc.subjectmale
dc.subjectretrospective study
dc.subjectrisk factor
dc.subjectthorax pain
dc.subjectthorax radiography
dc.subjecttuberculosis
dc.subjectadolescent
dc.subjectantagonists and inhibitors
dc.subjectcase control study
dc.subjectcomplication
dc.subjecthospitalization
dc.subjectInflammatory Bowel Diseases
dc.subjectmiddle aged
dc.subjectrisk factor
dc.subjectSpain
dc.subjectstatistics and numerical data
dc.subjecttuberculosis
dc.subjectyoung adult
dc.subjectAdalimumab
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAntibodies, Monoclonal
dc.subjectCase-Control Studies
dc.subjectFemale
dc.subjectHospitalization
dc.subjectHumans
dc.subjectInflammatory Bowel Diseases
dc.subjectInfliximab
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectRetrospective Studies
dc.subjectRisk Factors
dc.subjectSpain
dc.subjectTuberculosis
dc.subjectTumor Necrosis Factor-alpha
dc.subjectYoung Adult
dc.titleRisk factors for tuberculosis in inflammatory bowel disease: Anti-tumor necrosis factor and hospitalization
dc.typeArticle


Este ítem pertenece a la siguiente institución